Proceedings of a Clinical Roundtable
A supplement to Skin & Allergy News
Supported by Chester Valley Pharmaceuticals.
The articles in this supplement are based on a faculty clinical roundtable discussion. It was produced in affiliation with Skin Disease Education Foundation's 30th Annual Hawaii Dermatology Seminar, a medical education program held February 11-18, 2006, in Kauai, Hawaii.
•Topics
•Faculty/Faculty Disclosure Statement
To view the supplement, click the image above.
Topics
• Introduction: The Clinical Landscape of Atopic Dermatitis
• Recent Developments in the Management of Atopic Dermatitis
• Quality-of-Life Issues
• Infection in Atopic Dermatitis
• Conventional Treatment Options: Corticosteroids, Calcineurin Inhibitors
• Safety Issues
• New Nonsteroidal Option
Faculty/Faculty Disclosure Statement
Lawrence F. Eichenfield, MD, Chair
Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Chief, Pediatric and Adolescent Dermatology
Medical Director of Research
Children's Hospital and Health Center
San Diego
Dr. Eichenfield has received funding for a clinical study from Sinclair Pharma PLC.
Sarah L. Chamlin, MD
Assistant Professor of Pediatrics and Dermatology
Children's Memorial Hospital, Chicago
Northwestern University, Feinberg School of Medicine
Chicago
Dr. Chamlin is a consultant to Astellas Pharma Inc.
Sheila Fallon Friedlander, MD
Director, Fellowship Training Program
Pediatric and Adolescent Dermatology
Children's Hospital and Health Center, San Diego
Clinical Professor of Pediatrics and Medicine (Dermatology)
University of California, San Diego, School of Medicine
Dr. Friedlander is a consultant to Astellas, Connetics Corporation, GlaxoSmithKline, and Novartis AG.
Wm. Philip Werschler, MD, FAAD, FAACS
Assistant Clinical Professor in Medicine/Dermatology
University of Washington
Seattle
Dr. Werschler has nothing to disclose.
Copyright © 2006 Elsevier Inc.